The global Biopharmaceutical Fermentation Systems market was valued at US$ 1643 million in 2023 and is anticipated to reach US$ 2265.4 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.

Biopharmaceutical Fermentation Systems Market

Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.

In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Fermentation Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Fermentation Systems.

Report Scope

The Biopharmaceutical Fermentation Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Fermentation Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical Fermentation Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical Fermentation Systems Market Report

Report Metric	Details
Report Name	Biopharmaceutical Fermentation Systems Market
Accounted market size in 2023	US$ 1643 million
Forecasted market size in 2030	US$ 2265.4 million
CAGR	4.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Fermenters Bioprocess Analyzers Process Monitoring Devices Culture & Media Preparation Culture Media, Buffers & Inducers Others
Segment by Application	Biopharmaceutical Companies Contract Manufacturing Organizations Contract Research Organizations Academic Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Thermo Fisher Scientific, Danaher, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals, Lonza, Becton, Dickinson and Company, GEA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Fermentation Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biopharmaceutical Fermentation Systems Market growing?

Ans: The Biopharmaceutical Fermentation Systems Market witnessing a CAGR of 4.7% during the forecast period 2024-2030.

What is the Biopharmaceutical Fermentation Systems Market size in 2030?

Ans: The Biopharmaceutical Fermentation Systems Market size in 2030 will be US$ 2265.4 million.

Who are the main players in the Biopharmaceutical Fermentation Systems Market report?

Ans: The main players in the Biopharmaceutical Fermentation Systems Market are GE Healthcare, Thermo Fisher Scientific, Danaher, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals, Lonza, Becton, Dickinson and Company, GEA

What are the Application segmentation covered in the Biopharmaceutical Fermentation Systems Market report?

Ans: The Applications covered in the Biopharmaceutical Fermentation Systems Market report are Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Others

What are the Type segmentation covered in the Biopharmaceutical Fermentation Systems Market report?

Ans: The Types covered in the Biopharmaceutical Fermentation Systems Market report are Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture & Media Preparation, Culture Media, Buffers & Inducers, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical Fermentation Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Fermenters

1.2.3 Bioprocess Analyzers

1.2.4 Process Monitoring Devices

1.2.5 Culture & Media Preparation

1.2.6 Culture Media, Buffers & Inducers

1.2.7 Others

1.3 Market by Application

1.3.1 Global Biopharmaceutical Fermentation Systems Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biopharmaceutical Companies

1.3.3 Contract Manufacturing Organizations

1.3.4 Contract Research Organizations

1.3.5 Academic Research Institutes

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical Fermentation Systems Market Perspective (2019-2030)

2.2 Biopharmaceutical Fermentation Systems Growth Trends by Region

2.2.1 Global Biopharmaceutical Fermentation Systems Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biopharmaceutical Fermentation Systems Historic Market Size by Region (2019-2024)

2.2.3 Biopharmaceutical Fermentation Systems Forecasted Market Size by Region (2025-2030)

2.3 Biopharmaceutical Fermentation Systems Market Dynamics

2.3.1 Biopharmaceutical Fermentation Systems Industry Trends

2.3.2 Biopharmaceutical Fermentation Systems Market Drivers

2.3.3 Biopharmaceutical Fermentation Systems Market Challenges

2.3.4 Biopharmaceutical Fermentation Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical Fermentation Systems Players by Revenue

3.1.1 Global Top Biopharmaceutical Fermentation Systems Players by Revenue (2019-2024)

3.1.2 Global Biopharmaceutical Fermentation Systems Revenue Market Share by Players (2019-2024)

3.2 Global Biopharmaceutical Fermentation Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical Fermentation Systems Revenue

3.4 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio

3.4.1 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Fermentation Systems Revenue in 2023

3.5 Biopharmaceutical Fermentation Systems Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical Fermentation Systems Product Solution and Service

3.7 Date of Enter into Biopharmaceutical Fermentation Systems Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Fermentation Systems Breakdown Data by Type

4.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Type (2019-2024)

4.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Type (2025-2030)

5 Biopharmaceutical Fermentation Systems Breakdown Data by Application

5.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Application (2019-2024)

5.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biopharmaceutical Fermentation Systems Market Size (2019-2030)

6.2 North America Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)

6.4 North America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical Fermentation Systems Market Size (2019-2030)

7.2 Europe Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)

7.4 Europe Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size (2019-2030)

8.2 Asia-Pacific Biopharmaceutical Fermentation Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2019-2024)

8.4 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical Fermentation Systems Market Size (2019-2030)

9.2 Latin America Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)

9.4 Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (2019-2030)

10.2 Middle East & Africa Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)

10.4 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Detail

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Biopharmaceutical Fermentation Systems Introduction

11.1.4 GE Healthcare Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.1.5 GE Healthcare Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Detail

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Introduction

11.2.4 Thermo Fisher Scientific Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Danaher

11.3.1 Danaher Company Detail

11.3.2 Danaher Business Overview

11.3.3 Danaher Biopharmaceutical Fermentation Systems Introduction

11.3.4 Danaher Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.3.5 Danaher Recent Development

11.4 Sartorius StedimBiotech

11.4.1 Sartorius StedimBiotech Company Detail

11.4.2 Sartorius StedimBiotech Business Overview

11.4.3 Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Introduction

11.4.4 Sartorius StedimBiotech Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.4.5 Sartorius StedimBiotech Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Biopharmaceutical Fermentation Systems Introduction

11.5.4 Merck Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Eppendorf

11.6.1 Eppendorf Company Detail

11.6.2 Eppendorf Business Overview

11.6.3 Eppendorf Biopharmaceutical Fermentation Systems Introduction

11.6.4 Eppendorf Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.6.5 Eppendorf Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Biopharmaceutical Fermentation Systems Introduction

11.7.4 Roche Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.7.5 Roche Recent Development

11.8 Nova Biomedicals

11.8.1 Nova Biomedicals Company Detail

11.8.2 Nova Biomedicals Business Overview

11.8.3 Nova Biomedicals Biopharmaceutical Fermentation Systems Introduction

11.8.4 Nova Biomedicals Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.8.5 Nova Biomedicals Recent Development

11.9 Lonza

11.9.1 Lonza Company Detail

11.9.2 Lonza Business Overview

11.9.3 Lonza Biopharmaceutical Fermentation Systems Introduction

11.9.4 Lonza Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.9.5 Lonza Recent Development

11.10 Becton

11.10.1 Becton Company Detail

11.10.2 Becton Business Overview

11.10.3 Becton Biopharmaceutical Fermentation Systems Introduction

11.10.4 Becton Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.10.5 Becton Recent Development

11.11 Dickinson and Company

11.11.1 Dickinson and Company Company Detail

11.11.2 Dickinson and Company Business Overview

11.11.3 Dickinson and Company Biopharmaceutical Fermentation Systems Introduction

11.11.4 Dickinson and Company Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.11.5 Dickinson and Company Recent Development

11.12 GEA

11.12.1 GEA Company Detail

11.12.2 GEA Business Overview

11.12.3 GEA Biopharmaceutical Fermentation Systems Introduction

11.12.4 GEA Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)

11.12.5 GEA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GE Healthcare

Thermo Fisher Scientific

Danaher

Sartorius StedimBiotech

Dickinson and Company

GEA

List of Tables

Table 1. Global Biopharmaceutical Fermentation Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Fermenters

Table 3. Key Players of Bioprocess Analyzers

Table 4. Key Players of Process Monitoring Devices

Table 5. Key Players of Culture & Media Preparation

Table 6. Key Players of Culture Media, Buffers & Inducers

Table 7. Key Players of Others

Table 8. Global Biopharmaceutical Fermentation Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Biopharmaceutical Fermentation Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Biopharmaceutical Fermentation Systems Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Biopharmaceutical Fermentation Systems Market Share by Region (2019-2024)

Table 12. Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Biopharmaceutical Fermentation Systems Market Share by Region (2025-2030)

Table 14. Biopharmaceutical Fermentation Systems Market Trends

Table 15. Biopharmaceutical Fermentation Systems Market Drivers

Table 16. Biopharmaceutical Fermentation Systems Market Challenges

Table 17. Biopharmaceutical Fermentation Systems Market Restraints

Table 18. Global Biopharmaceutical Fermentation Systems Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Biopharmaceutical Fermentation Systems Market Share by Players (2019-2024)

Table 20. Global Top Biopharmaceutical Fermentation Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Fermentation Systems as of 2023)

Table 21. Ranking of Global Top Biopharmaceutical Fermentation Systems Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Biopharmaceutical Fermentation Systems Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Biopharmaceutical Fermentation Systems Product Solution and Service

Table 25. Date of Enter into Biopharmaceutical Fermentation Systems Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Biopharmaceutical Fermentation Systems Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Biopharmaceutical Fermentation Systems Revenue Market Share by Type (2019-2024)

Table 29. Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Biopharmaceutical Fermentation Systems Revenue Market Share by Type (2025-2030)

Table 31. Global Biopharmaceutical Fermentation Systems Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Biopharmaceutical Fermentation Systems Revenue Market Share by Application (2019-2024)

Table 33. Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Biopharmaceutical Fermentation Systems Revenue Market Share by Application (2025-2030)

Table 35. North America Biopharmaceutical Fermentation Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Biopharmaceutical Fermentation Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Biopharmaceutical Fermentation Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Biopharmaceutical Fermentation Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Biopharmaceutical Fermentation Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030) & (US$ Million)

Table 50. GE Healthcare Company Detail

Table 51. GE Healthcare Business Overview

Table 52. GE Healthcare Biopharmaceutical Fermentation Systems Product

Table 53. GE Healthcare Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 54. GE Healthcare Recent Development

Table 55. Thermo Fisher Scientific Company Detail

Table 56. Thermo Fisher Scientific Business Overview

Table 57. Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Product

Table 58. Thermo Fisher Scientific Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 59. Thermo Fisher Scientific Recent Development

Table 60. Danaher Company Detail

Table 61. Danaher Business Overview

Table 62. Danaher Biopharmaceutical Fermentation Systems Product

Table 63. Danaher Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 64. Danaher Recent Development

Table 65. Sartorius StedimBiotech Company Detail

Table 66. Sartorius StedimBiotech Business Overview

Table 67. Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Product

Table 68. Sartorius StedimBiotech Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 69. Sartorius StedimBiotech Recent Development

Table 70. Merck Company Detail

Table 71. Merck Business Overview

Table 72. Merck Biopharmaceutical Fermentation Systems Product

Table 73. Merck Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 74. Merck Recent Development

Table 75. Eppendorf Company Detail

Table 76. Eppendorf Business Overview

Table 77. Eppendorf Biopharmaceutical Fermentation Systems Product

Table 78. Eppendorf Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 79. Eppendorf Recent Development

Table 80. Roche Company Detail

Table 81. Roche Business Overview

Table 82. Roche Biopharmaceutical Fermentation Systems Product

Table 83. Roche Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 84. Roche Recent Development

Table 85. Nova Biomedicals Company Detail

Table 86. Nova Biomedicals Business Overview

Table 87. Nova Biomedicals Biopharmaceutical Fermentation Systems Product

Table 88. Nova Biomedicals Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 89. Nova Biomedicals Recent Development

Table 90. Lonza Company Detail

Table 91. Lonza Business Overview

Table 92. Lonza Biopharmaceutical Fermentation Systems Product

Table 93. Lonza Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 94. Lonza Recent Development

Table 95. Becton Company Detail

Table 96. Becton Business Overview

Table 97. Becton Biopharmaceutical Fermentation Systems Product

Table 98. Becton Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 99. Becton Recent Development

Table 100. Dickinson and Company Company Detail

Table 101. Dickinson and Company Business Overview

Table 102. Dickinson and Company Biopharmaceutical Fermentation Systems Product

Table 103. Dickinson and Company Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 104. Dickinson and Company Recent Development

Table 105. GEA Company Detail

Table 106. GEA Business Overview

Table 107. GEA Biopharmaceutical Fermentation Systems Product

Table 108. GEA Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024) & (US$ Million)

Table 109. GEA Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical Fermentation Systems Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biopharmaceutical Fermentation Systems Market Share by Type: 2023 VS 2030

Figure 3. Fermenters Features

Figure 4. Bioprocess Analyzers Features

Figure 5. Process Monitoring Devices Features

Figure 6. Culture & Media Preparation Features

Figure 7. Culture Media, Buffers & Inducers Features

Figure 8. Others Features

Figure 9. Global Biopharmaceutical Fermentation Systems Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Biopharmaceutical Fermentation Systems Market Share by Application: 2023 VS 2030

Figure 11. Biopharmaceutical Companies Case Studies

Figure 12. Contract Manufacturing Organizations Case Studies

Figure 13. Contract Research Organizations Case Studies

Figure 14. Academic Research Institutes Case Studies

Figure 15. Others Case Studies

Figure 16. Biopharmaceutical Fermentation Systems Report Years Considered

Figure 17. Global Biopharmaceutical Fermentation Systems Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Biopharmaceutical Fermentation Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Biopharmaceutical Fermentation Systems Market Share by Region: 2023 VS 2030

Figure 20. Global Biopharmaceutical Fermentation Systems Market Share by Players in 2023

Figure 21. Global Top Biopharmaceutical Fermentation Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Fermentation Systems as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Biopharmaceutical Fermentation Systems Revenue in 2023

Figure 23. North America Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Biopharmaceutical Fermentation Systems Market Share by Country (2019-2030)

Figure 25. United States Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Biopharmaceutical Fermentation Systems Market Share by Country (2019-2030)

Figure 29. Germany Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Biopharmaceutical Fermentation Systems Market Share by Region (2019-2030)

Figure 37. China Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Biopharmaceutical Fermentation Systems Market Share by Country (2019-2030)

Figure 45. Mexico Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Biopharmaceutical Fermentation Systems Market Share by Country (2019-2030)

Figure 49. Turkey Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Biopharmaceutical Fermentation Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. GE Healthcare Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 53. Danaher Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 54. Sartorius StedimBiotech Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 56. Eppendorf Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 58. Nova Biomedicals Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 59. Lonza Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 60. Becton Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 61. Dickinson and Company Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 62. GEA Revenue Growth Rate in Biopharmaceutical Fermentation Systems Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Veterinary Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31X6782

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Coating Devcie Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7E13021

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Animal Antibacterial Peptide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20G6893

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Medical Biological Indicator Incubator Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34Y12560

Fri May 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions